Google spinoff sees AI drug trials this year
Wall Street Breakfast
00:00
AI-Driven Drug Trials and Market Insights
This chapter explores Isomorphic Labs' plans to initiate AI-designed drug clinical trials, aiming to transform the drug discovery landscape. It also examines industry feedback and market trends, alongside insights into stock performance and future forecasts.
Transcript
Play full episode
